Paper2552872
Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication.
Weiss RC. Am J Vet Res, 1989. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication. Papers, record 2552872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2552872
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acyclovir | Major topic |
| Herpesviridae | Major topic |
| Interferon Type I | Major topic |
| Virus Replication | Major topic |
| Animals | |
| Cat Diseases | |
| Cats | |
| Cell Line | |
| Dose-Response Relationship, Drug | |
| Drug Synergism | |
| Herpesviridae Infections | |
| Humans | |
| Recombinant Proteins | |
| Respiratory Tract Infections |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38311324 | Clinical and inflammatory response to antiviral treatments in dogs with parvoviral enteritis. | J Vet Sci | 2024 | https://conductscience.org/library/papers/38311324 | PubMed |
| 27091747 | A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1. | Vet Ophthalmol | 2016 | https://conductscience.org/library/papers/27091747 | PubMed |
| 23813810 | ABCD: Update of the 2009 guidelines on prevention and management of feline infectious diseases. | J Feline Med Surg | 2013 | https://conductscience.org/library/papers/23813810 | PubMed |
| 21515221 | Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options. | J Feline Med Surg | 2011 | https://conductscience.org/library/papers/21515221 | PubMed |
| 19481034 | Feline herpesvirus infection. ABCD guidelines on prevention and management. | J Feline Med Surg | 2009 | https://conductscience.org/library/papers/19481034 | PubMed |
| 16640781 | In vitro comparison of antiviral drugs against feline herpesvirus 1. | BMC Vet Res | 2006 | https://conductscience.org/library/papers/16640781 | PubMed |
| 11716625 | Ocular manifestations of feline herpesvirus. | J Feline Med Surg | 2001 | https://conductscience.org/library/papers/11716625 | PubMed |
| 7515537 | Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. | Vet Microbiol | 1994 | https://conductscience.org/library/papers/7515537 | PubMed |
| 2549687 | Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro. | Vet Microbiol | 1989 | https://conductscience.org/library/papers/2549687 | PubMed |
| 2178336 | Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2178336 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2552872
GET https://conductscience.org/api/papers/v1/2552872/authors